ACADIA Pharmaceuticals Inc. (ACAD) vs Tarsus Pharmaceuticals, Inc. (TARS)
- ACADIA Pharmaceuticals Inc. ACAD 19.12 −2.99%
- Tarsus Pharmaceuticals, Inc. TARS 68.07 −4.11%
ACADIA Pharmaceuticals Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. ACADIA Pharmaceuticals Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.5B and $3.4B). Tarsus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; ACADIA Pharmaceuticals Inc. trades at 8.5×. Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 105.2% against 11.8%. ACADIA Pharmaceuticals Inc. has the higher net margin (33.4% vs −7.67%) and the higher return on invested capital (15.4% vs 0.00%). Across the 17 metrics below, ACADIA Pharmaceuticals Inc. leads on 14 and Tarsus Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ACAD | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.13% | 93.28% | 65.16% |
| Operating margin | 7.59% | (8.00%) | 0.00% |
| Net margin | 33.42% | (7.67%) | 0.00% |
| Free cash flow margin | 12.79% | 9.24% | 0.00% |
| Return on equity | 35.74% | (13.68%) | (56.36%) |
| Return on assets | 25.64% | (8.40%) | (48.04%) |
| Return on invested capital | 15.42% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack